Exelixis Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
Trump Announces Plan To Reign In Drug Prices And Pharma Stocks Rally
Article By: Zacks Investment Research
Sunday, May 13, 2018 11:37 AM EDT
President Trump unveiled his plan to control US drug prices. Stock prices of the biggest drug companies briefly declined, only to reverse course and ended the day broadly higher. The reason? The plan doesn’t seem to be “taking them on” at all.
In this article: LLY, MRK, AMGN, EXEL, ABBV
Bull Of The Day: Exelixis
Article By: Kevin Cook
Friday, May 11, 2018 9:55 AM EDT
Unique among small biotech companies, EXEL is a profitable mid-cap cancer fighter with projected 58% revenue growth and 68% EPS growth this year.
In this article: EXEL
Exelixis, Roche Slide After Colon Cancer Drug Fails To Meet Primary Study Goal
Article By: The Fly
Thursday, May 10, 2018 12:50 PM EDT
Shares of Exelixis and partner Roche are under pressure this morning after the companies announced that the Phase 3 IMblaze370 trial did not achieve statistical-significance on the primary efficacy endpoint.
In this article: RHHBY, EXEL Also: BMY, MRK, ARRY
4 Biotech Stocks To Watch In The New Year
Article By: Zacks Investment Research
Sunday, January 7, 2018 5:23 PM EDT
Biotech companies are continuously working on bringing innovative new treatments to market, and there could be significant catalysts in the coming quarters in the form of important product approvals as well as major data read-outs.
In this article: EBS, GSK, MDCO, XOMA, EXEL, NVS, MLNT
Exelixis Surges After Cabometyx Granted Priority Review, Meets Endpoint In Trial
Article By: The Fly
Monday, October 16, 2017 12:50 PM EDT
Shares of Exelixis jumped in early trading after the biopharmaceutical company said it received priority review from the U.S. Food and Drug Administration for a treatment for advanced renal cell carcinoma.
In this article: EXEL Also: IPSEY, BAYRY


Latest Tweets for $EXEL

No tweets yet!